Diagnostic and response assessment FDG PET‐CT in neurolymphomatosis

FDG PET‐CT is a useful imaging tool in the diagnosis and response assessment of neurolymphomatosis, especially in cases of otherwise unexplained neuropathy following conventional diagnostic work‐up including lumbar puncture, CT, and MRI. The use of a novel PET reconstruction algorithm improves image...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruce, David, Eagleton, Helen, Subesinghe, Manil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134268/
https://www.ncbi.nlm.nih.gov/pubmed/27980756
http://dx.doi.org/10.1002/ccr3.734
_version_ 1782471432785100800
author Bruce, David
Eagleton, Helen
Subesinghe, Manil
author_facet Bruce, David
Eagleton, Helen
Subesinghe, Manil
author_sort Bruce, David
collection PubMed
description FDG PET‐CT is a useful imaging tool in the diagnosis and response assessment of neurolymphomatosis, especially in cases of otherwise unexplained neuropathy following conventional diagnostic work‐up including lumbar puncture, CT, and MRI. The use of a novel PET reconstruction algorithm improves image quality and lesion detection through increased signal‐to‐noise ratio.
format Online
Article
Text
id pubmed-5134268
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-51342682016-12-15 Diagnostic and response assessment FDG PET‐CT in neurolymphomatosis Bruce, David Eagleton, Helen Subesinghe, Manil Clin Case Rep Case Reports FDG PET‐CT is a useful imaging tool in the diagnosis and response assessment of neurolymphomatosis, especially in cases of otherwise unexplained neuropathy following conventional diagnostic work‐up including lumbar puncture, CT, and MRI. The use of a novel PET reconstruction algorithm improves image quality and lesion detection through increased signal‐to‐noise ratio. John Wiley and Sons Inc. 2016-10-28 /pmc/articles/PMC5134268/ /pubmed/27980756 http://dx.doi.org/10.1002/ccr3.734 Text en © 2016 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Bruce, David
Eagleton, Helen
Subesinghe, Manil
Diagnostic and response assessment FDG PET‐CT in neurolymphomatosis
title Diagnostic and response assessment FDG PET‐CT in neurolymphomatosis
title_full Diagnostic and response assessment FDG PET‐CT in neurolymphomatosis
title_fullStr Diagnostic and response assessment FDG PET‐CT in neurolymphomatosis
title_full_unstemmed Diagnostic and response assessment FDG PET‐CT in neurolymphomatosis
title_short Diagnostic and response assessment FDG PET‐CT in neurolymphomatosis
title_sort diagnostic and response assessment fdg pet‐ct in neurolymphomatosis
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134268/
https://www.ncbi.nlm.nih.gov/pubmed/27980756
http://dx.doi.org/10.1002/ccr3.734
work_keys_str_mv AT brucedavid diagnosticandresponseassessmentfdgpetctinneurolymphomatosis
AT eagletonhelen diagnosticandresponseassessmentfdgpetctinneurolymphomatosis
AT subesinghemanil diagnosticandresponseassessmentfdgpetctinneurolymphomatosis

Ejemplares similares